AN2 Therapeutics to Participate in 9th Annual Evercore Healthcare Conference

AN2 Therapeutics to Participate in 9th Annual Evercore Healthcare Conference

MENLO PARK, Calif.–(BUSINESS WIRE)–AN2 Therapeutics, Inc. (NASDAQ: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, Co-Founder, Chairman, President and CEO will participate in a fireside chat at the 9th Annual Evercore Healthcare Conference on Wednesday, December 2, 2026 at 8:20am ET and members of management will be available for 1×1 meetings.

A webcast of the fireside chat can be accessed on the Investors section of the AN2 Therapeutics website at www.an2therapeutics.com. An archived replay will be available for at least 30 days following the presentation.

About AN2 Therapeutics, Inc.

AN2 Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on the discovery and development of novel small-molecule therapeutics derived from its boron chemistry platform. For more information please visit our website at www.an2therapeutics.com.

COMPANY CONTACT:
Lucy O. Day
Chief Financial Officer
[email protected]

INVESTOR AND MEDIA CONTACT:
Anne Bowdidge
[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Health Infectious Diseases Clinical Trials Research Science Pharmaceutical Biotechnology

MEDIA:

Logo
Logo